Archives: trenbolone enanthate

trenbolone enanthate

Antacids reduce the bioavailability of ACE inhibitors. Glucocorticoids, nonsteroidal anti-inflammatory drugs reduce the severity of the hypotensive effect (fluid retention and electrolyte).Potassium-sparing diuretics (spironolactone, triamterene, amiloride), potassium supplements increase the risk of hyperkalemia. Not trenbolone enanthaterecommended simultaneous application of drugs that may cause hyperkalemia, and ACE inhibitors, except in cases of severe hypokalemia (potassium control serum). • Read More »